Citing new data, Pfizer outlined a case for booster shots, but there’s a debate over whether they’re needed.

By BY CARL ZIMMER, APOORVA MANDAVILLI, SHARON LAFRANIERE AND REBECCA ROBBINS from NYT Health While its coronavirus vaccine may become slightly weaker over time, getting two doses remains remarkably effective, according to the data. https://ift.tt/3BJMLdQ